GIORDANO, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 3.913
EU - Europa 2.411
AS - Asia 453
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
SA - Sud America 7
Totale 6.928
Nazione #
US - Stati Uniti d'America 3.804
UA - Ucraina 906
DE - Germania 529
SE - Svezia 285
IT - Italia 277
AT - Austria 264
CN - Cina 167
SN - Senegal 122
TR - Turchia 111
CA - Canada 104
IN - India 76
FI - Finlandia 53
HK - Hong Kong 35
KR - Corea 32
GB - Regno Unito 27
FR - Francia 23
BE - Belgio 18
EU - Europa 11
IR - Iran 10
AU - Australia 9
NL - Olanda 9
SG - Singapore 7
RU - Federazione Russa 6
SA - Arabia Saudita 6
MX - Messico 5
BR - Brasile 4
PT - Portogallo 4
BG - Bulgaria 3
CH - Svizzera 3
EG - Egitto 2
PE - Perù 2
BD - Bangladesh 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
PH - Filippine 1
PK - Pakistan 1
VN - Vietnam 1
Totale 6.928
Città #
Chandler 732
Jacksonville 524
San Mateo 345
Dearborn 268
New York 230
Vienna 180
Ashburn 173
Roxbury 130
Lawrence 128
Dakar 122
Izmir 99
Ottawa 85
Des Moines 83
Rende 81
Shanghai 67
Inglewood 63
Bremen 59
Brooklyn 53
Helsinki 53
Ann Arbor 52
Wilmington 51
Grafing 49
Beijing 41
Ogden 41
Florence 36
Hong Kong 34
Seoul 32
Pune 29
Seattle 29
Redwood City 24
Cambridge 20
Brussels 18
San Francisco 17
Toronto 17
Augusta 13
Monmouth Junction 13
Los Angeles 11
Hanover 10
Houston 9
Jinan 9
Hefei 8
Washington 8
Kocaeli 7
Mountain View 7
Ningbo 7
Norwalk 7
Boardman 6
Kilburn 6
Riyadh 6
Singapore 6
Ardabil 5
Bangalore 5
Cosenza 5
Falkenstein 5
Falls Church 5
Leawood 5
Trebaseleghe 5
Bari 4
Castrovillari 4
Chicago 4
Frankfurt am Main 4
Haikou 4
Hebei 4
Kunming 4
London 4
Nanjing 4
Naples 4
Rome 4
Santarcangelo di Romagna 4
Sydney 4
Amsterdam 3
Belvedere Marittimo 3
Bisignano 3
Böblingen 3
Catanzaro 3
Fano 3
Ferentino 3
Hangzhou 3
Livorno 3
Melbourne 3
Milan 3
Naaldwijk 3
San Giuliano Milanese 3
San Jose 3
Zhengzhou 3
Berlin 2
Bianco 2
Cairo 2
Canberra 2
Casal Di Principe 2
Castrolibero 2
Catania 2
Costa Mesa 2
Curtarolo 2
Esslingen am Neckar 2
Formia 2
Fremont 2
Groningen 2
Gunzenhausen 2
Kish 2
Totale 4.260
Nome #
Androgens inhibit aromatase expression through DAX-1: disclosing the molecular link between hormone balance and leydig cancer development. 94
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network 93
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 89
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression 89
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 87
Adherence to the Mediterranean diet pattern among university staff: a cross-sectional web-based epidemiological study in Southern Italy 84
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 82
Activated Farnesoid X Receptor inhibits growth of tamoxifen-resistant breast cancer cells. 81
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 81
Impact of Vigorous-Intensity Physical Activity on Body Composition Parameters, Lipid Profile Markers, and Irisin Levels in Adolescents: A Cross-Sectional Study. 80
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 79
Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development 79
Benzofuran-2-acetic ester derivatives induce apoptosis in breast cancer cells by upregulating p21Cip/WAF1 gene expression in p53-independent manner 79
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 78
Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells 77
Aromatase expression in prepuberal Sertoli cells: effects of thyroid hormone 77
DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation 77
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication 75
Antiproliferative and autophagic effects of omega-3 EPA and DHA-dopamine conjugates in human breast cancer cells. 73
Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness 73
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 73
A new role of leptin as amplifier of estrogen signaling in breast cancer. 72
Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells 71
Endemic goiter and iodine prophylaxis in Calabria, a region of Southern Italy: Past and present 71
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis 71
Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth 71
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 71
Androgen receptor activation inhibits the genomic effect of estradiol in MCF-7 cells. A molecular basis of its antiproliferative action 70
Aromatase expression in prepuberal Sertoli cells: effect of thyroid hormone 70
N-Eicosapentaenoyl Dopamine, a Conjugate of Dopamine and Eicosapentaenoic Acid (EPA), Exerts Anti-inflammatory Properties in Mouse and Human Macrophages 69
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 69
Evidences that leptin upregulates E-cadherin expression in breast cancer and promotes tumor cell growth and progression 68
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 68
AR/ER coactivator squelcing contributes to the inhibition of estrogen-dependent cyclin D1 expression in breast cancer 66
Activated Farnesoid X Receptor Inhibits Growth of Tamoxifen-Resistant MCF-7 Breast Cancer Cells, through down-Regulation of HER2 Expression. 65
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter 64
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 64
The Role of PPARγ Ligands in Breast Cancer: from Basic Research to Clinical Studies 64
Oldenlandia Diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation 63
Identification of novel 2-(1 H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth & motility 63
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity 62
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 62
Development of a Leptin Antagonist Peptide: Implications for Breast Cancer 61
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression 60
Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells 60
May tumor microenvironment cooperate with a mutant ERalpha to promote breast cancer progression? 60
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 60
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 59
Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression 59
Impact of Mediterranean Diet Food Choices and Physical Activity on Serum Metabolic Profile in Healthy Adolescents: Findings from the DIMENU Project 57
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth. 56
FXR ligands, by interfering with tumor/microenvironment crosstalk, inhibit breast tumor growth and progression. 56
Potential antioxidant and anti-inflammatory properties of serum from healthy adolescents with optimal mediterranean diet adherence: findings from DIMENU cross-sectional study 56
A Palladium-Catalyzed Carbonylation Approach to Eight-Membered Lactam Derivatives with Antitumor Activity 55
Nutrition Education Program and Physical Activity Improve the Adherence to the Mediterranean Diet: Impact on Inflammatory Biomarker Levels in Healthy Adolescents From the DIMENU Longitudinal Study 55
Role of Farnesoid X Receptor Activation in Counteracting Tumor-promoting Functions of Cancer-Associated Fibroblasts in Breast Cancers 54
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells 54
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity. 54
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 53
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 53
Rapid estradiol/ER{alpha} signaling enhances aromatase enzymatic activity in breast cancer cells 52
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 52
Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway 52
Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element 52
Effects of triiodothyronine (T3) on alternative splicing events in the coding region of P450 aromatase in immature Sertoli cells. 52
Effect of T3 on aromatase and estrogen receptor content in peripuberal Sertoli cells 52
Obesity, leptin and breast cancer: Epidemiological evidence and proposed mechanisms 52
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy 51
Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line 51
Leptin, obesity and breast cancer: progress to understanding the molecular connections 51
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 51
Estrogen Receptor-β, through Sp1, Recruits a Corepressor Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 50
Farnesoid X receptor in human malignancies: an overview 50
Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes 49
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells. 49
Evidence that estradiol through non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 48
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 48
The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression 48
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 48
Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells. 47
Monitoring the effects of iodine prophylaxis in the adult population of southern Italy with deficient and sufficient iodine intake levels: a cross-sectional, epidemiological study 47
The biology of exosomes in breast cancer progression: Dissemination, immune evasion and metastatic colonization 47
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo 47
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305 46
Phosphodiesterase type 5 promotes the invasive potential of breast cancer cells through Rho GTPase activation. 46
Natural and synthetic PPARγ ligands in tumor microenvironment: a new potential strategy against breast cancer 46
n–3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer 46
Nutraceuticals in the mediterranean diet: Potential avenues for breast cancer treatment 46
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 45
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 44
Effects of tri-iodothyronine on alternative splicing events in the coding region of cytochrome P450 aromatase in immature rat Sertoli cells 44
Molecular mechanism through which leptin upregulates e-cadherin expression and influences breast cancer cell growth and progression 43
Fas Ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor α interaction via sp-1. 42
Expression and Function of Androgen Receptor in Human Breast Cancer-Associated Fibroblasts: May Androgens Shape Breast Tumor Microenvironment? 42
The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives 42
Targeting Breast Cancer-associated Fibroblasts with Farnesoid X Receptor Ligands as a Novel Treatyment Strategy for Breast Cancer. 41
Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets 41
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 41
Farnesoid X receptor, through the binding with steroidogenic factor 1 responsive element, inhibits aromatase expression in tumor leydig cells 41
The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer 41
Totale 6.019
Categoria #
all - tutte 44.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019125 0 0 0 0 0 0 0 0 0 24 99 2
2019/20201.165 106 106 8 116 68 268 95 133 34 23 122 86
2020/20211.019 131 8 123 128 13 122 27 124 77 132 42 92
2021/20221.683 32 241 21 143 171 60 8 384 34 10 218 361
2022/20231.790 228 229 71 199 242 156 18 239 200 43 98 67
2023/20241.117 149 63 104 56 81 400 30 86 99 49 0 0
Totale 7.171